Experts Respond to Aduhelm Approval
Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
A dementia diagnosis represents a new chapter in life: As people contend with the challenges that accompany the illness, they could also find new…
As part of our LiveTalk series, Being Patient spoke with Dr. Jason Karlawish about the early diagnosis of Alzheimer’s and why it’s important for…
Expressive arts like music, painting, and even dance have the potential to evoke powerful emotion and long-buried memories in people living with Alzheimer’s. For…
As part of our BrainTalk series, Being Patient spoke with Sandra Kooij about the symptoms and treatment options of ADHD for older adults and…
After the deaths of close family members and giving birth to her child, Kara Kirby began experiencing changes in her behavior and personality. Clinicians…
Biogen’s aducanumab — a human antibody-based drug that targets beta-amyloid plaques, which are found in the brains of people with Alzheimer’s — has gone…
There is growing recognition that repetitive head impacts increases the risk of CTE, a brain disease that can only be definitely diagnosed at autopsy….
After Brian LeBlanc was diagnosed with early-onset Alzheimer’s at the age of 54, he got involved in dementia advocacy and began speaking about his…
Dementia is a complex illness — one that is often misunderstood. The person’s age at the time of diagnosis, the severity of the symptoms…
Like many loved ones with a family member living with Alzheimer’s, TV host Leeza Gibbons and her family struggled to come to grips with…
As part of our BrainTalk series, newscaster Genevieve Glass speaks with Dr. Michael Geschwind about the causes of rapidly progressive dementias — relatively uncommon…
At the age of 46, John Wood was diagnosed with Alzheimer’s, but it wasn’t until about a year later that his diagnosis was revised…
Scientists are diversifying their approaches to finding an effective treatment for Alzheimer’s as clinical trials targeting beta-amyloid plaques, one of the hallmarks of the…
As part of our LiveTalk series, Being Patient spoke with John Gastil and movement disorder specialist Dr. Zoltan Mari about the symptoms, diagnosis and…